NO20010995L - Bioaktive peptider - Google Patents

Bioaktive peptider

Info

Publication number
NO20010995L
NO20010995L NO20010995A NO20010995A NO20010995L NO 20010995 L NO20010995 L NO 20010995L NO 20010995 A NO20010995 A NO 20010995A NO 20010995 A NO20010995 A NO 20010995A NO 20010995 L NO20010995 L NO 20010995L
Authority
NO
Norway
Prior art keywords
well
bioactive peptides
peptides
medicaments
cytotoxic
Prior art date
Application number
NO20010995A
Other languages
English (en)
Other versions
NO20010995D0 (no
NO333073B1 (no
Inventor
John Sigurd Svendsen
Oeystein Rekdal
Baldur Sveinbjoernsson
Lars Vorland
Original Assignee
Alpharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma As filed Critical Alpharma As
Publication of NO20010995D0 publication Critical patent/NO20010995D0/no
Publication of NO20010995L publication Critical patent/NO20010995L/no
Publication of NO333073B1 publication Critical patent/NO333073B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20010995A 1998-08-28 2001-02-27 Cytotoksiske peptider modifisert med en eller flere ikke-genetiske, voluminose og/eller lipofile aminosyrer. NO333073B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818938.4A GB9818938D0 (en) 1998-08-28 1998-08-28 Bioactive peptides
PCT/GB1999/002850 WO2000012541A2 (en) 1998-08-28 1999-08-31 Cytotoxic peptides modified by bulky or lipophilic moieties

Publications (3)

Publication Number Publication Date
NO20010995D0 NO20010995D0 (no) 2001-02-27
NO20010995L true NO20010995L (no) 2001-04-27
NO333073B1 NO333073B1 (no) 2013-02-25

Family

ID=10838089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010995A NO333073B1 (no) 1998-08-28 2001-02-27 Cytotoksiske peptider modifisert med en eller flere ikke-genetiske, voluminose og/eller lipofile aminosyrer.

Country Status (12)

Country Link
US (3) US7439228B2 (no)
EP (2) EP1109827B1 (no)
JP (1) JP5475937B2 (no)
AT (2) ATE495192T1 (no)
AU (2) AU772176B2 (no)
CA (2) CA2340326A1 (no)
DE (1) DE69943130D1 (no)
DK (1) DK1109831T3 (no)
ES (1) ES2359616T3 (no)
GB (1) GB9818938D0 (no)
NO (1) NO333073B1 (no)
WO (2) WO2000012541A2 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0605685D0 (en) * 2006-03-21 2006-05-03 Lytix Biopharma As Inhibition of tumour growth
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
GB0005702D0 (en) * 2000-03-09 2000-05-03 Alpharma As Method
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
KR20020080731A (ko) * 2001-04-17 2002-10-26 주식회사 이지바이오 시스템 락토페리신 유전자 및 이를 도입한 락토페리신 발현용형질전환체
KR100454595B1 (ko) * 2001-11-30 2004-10-28 주식회사 이지바이오 시스템 락토페리신 유전자 및 이를 도입한 형질전환 대장균
SE0200598D0 (sv) * 2002-02-27 2002-02-27 A & Science Invest Ab Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
ATE519499T1 (de) * 2002-05-10 2011-08-15 Agennix Inc Lactoferrin bei der behandlung maligner neoplasien und anderer hyperproliferativer erkrankungen
AU2003247826B2 (en) * 2002-06-28 2008-04-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
NO20031818D0 (no) * 2003-04-23 2003-04-23 Uni I Tromsoe Fremgangsmåte av bioaktiv peptid forberedelse
JP2007524654A (ja) * 2003-06-06 2007-08-30 エイジェニックス インコーポレイテッド 癌ワクチン中のアジュバントとしてのラクトフェリン
NZ544448A (en) 2004-03-19 2009-10-30 Morinaga Milk Industry Co Ltd Medicine for cancer therapy containing a lactoferrin hydrolysate and antibody
KR20100092031A (ko) * 2004-06-17 2010-08-19 맨카인드 코포레이션 에피토프 유사체
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
WO2006054908A1 (en) * 2004-11-19 2006-05-26 Fonterra Corporate Research And Development Limited Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
DE102005051366A1 (de) * 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
WO2007055578A1 (en) * 2005-11-11 2007-05-18 Leids Universitair Medisch Centrum Cyclic antimicrobial peptides derived from lactoferrin
DE602006020617D1 (de) 2005-12-30 2011-04-21 Evonik Roehm Gmbh Lactoferrin-peptide, geeignet als in die zelle eindringende peptide
ES2321358B1 (es) * 2006-04-05 2010-03-05 Consejo Susperior De Investigaciones Cientificas Uso de peptidos derivados de la lactoferrina para preparar formulaciones inhibidoras de la enzima conversora de angiotensina i.
WO2007126392A1 (en) * 2006-04-27 2007-11-08 Singapore Health Services Pte Ltd Antimicrobial peptides
AU2007272272B2 (en) 2006-07-10 2012-04-12 Pba3 Biomed Gmbh Antimicrobial peptides
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
EP2754450A1 (en) 2013-01-11 2014-07-16 Österreichische Akademie der Wissenschaften Lactoferricin derived peptides
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
CA2972397A1 (en) * 2014-10-08 2016-04-14 Nrl Pharma, Inc. Inhibitor of extracellular trap formation in leukocyte
ITUB20153058A1 (it) * 2015-08-11 2017-02-11 Farmagens Health Care S R L Roma ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?
US11213512B2 (en) 2016-06-21 2022-01-04 The Curators Of The University Of Missouri Bis-amino acid based compound and use thereof
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
US11364275B2 (en) 2017-08-04 2022-06-21 Bioventures, Llc Linear lipopeptide paenipeptins and methods of using the same
US11236138B2 (en) * 2020-01-14 2022-02-01 Renorigin Innovation Institute Co., Ltd. Peptide, method and composition for melanin polymerization and hair darkening
CN115073352A (zh) * 2022-06-28 2022-09-20 吉尔多肽生物制药(大连市)有限公司 一种2,5,7-三叔丁基色氨酸的合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141581A (en) * 1972-10-08 1992-08-25 Markham Harold A Implants with a cover which resists formation of firm spherical encapsulation
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US5073542A (en) 1989-06-07 1991-12-17 Magainin Sciences Inc. CPF peptide compositions and their use in inhibiting growth of target cells or a virus
DK167813B1 (da) 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5141851A (en) * 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
EP0503939B1 (en) * 1991-03-13 1997-06-18 Morinaga Milk Industry Co., Ltd. Antimicrobial peptide and antimicrobial agent
CA2111214A1 (en) * 1991-06-12 1992-12-23 W. Lee Maloy Composition and treatment with biologically active peptides having c-terminal substitutions
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
US5631228A (en) * 1991-11-01 1997-05-20 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
EP0644769A4 (en) * 1992-06-01 1995-08-09 Magainin Pharma BIOLOGICALLY ACTIVE PEPTIDES WITH N-TERMINAL SUBSTITUTIONS.
ATE225801T1 (de) * 1992-07-13 2002-10-15 Bionebraska Inc Verfahren zur modifizierung rekombinanter polypeptide
US5593866A (en) 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
JPH08507749A (ja) 1992-12-03 1996-08-20 マガイニン ファーマシューティカルズ，インク． 皮膚悪性疾患の生物学的活性を有するペプチドによる治療
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
BR9713166A (pt) * 1996-08-14 2000-02-01 Novartis Ag Peptideo com atividade inibidora para fungos patogênicos de plantas
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO1998040091A1 (en) * 1997-03-13 1998-09-17 The Research Foundation Of State University Of New York Microbicidal peptides and methods of use
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
GB9818938D0 (en) 1998-10-21
JP2002523517A (ja) 2002-07-30
US20080287346A1 (en) 2008-11-20
NO20010995D0 (no) 2001-02-27
US6890902B2 (en) 2005-05-10
AU5526899A (en) 2000-03-21
AU5526799A (en) 2000-03-21
EP1109831A2 (en) 2001-06-27
DE69943130D1 (de) 2011-02-24
JP5475937B2 (ja) 2014-04-16
EP1109831B1 (en) 2011-01-12
ES2359616T3 (es) 2011-05-25
US20030148936A1 (en) 2003-08-07
CA2340326A1 (en) 2000-03-09
EP1109827B1 (en) 2011-06-22
CA2341037C (en) 2013-11-05
CA2341037A1 (en) 2000-03-09
WO2000012541A3 (en) 2000-06-08
US20030022821A1 (en) 2003-01-30
EP1109827A2 (en) 2001-06-27
US8143211B2 (en) 2012-03-27
US7439228B2 (en) 2008-10-21
NO333073B1 (no) 2013-02-25
ATE513847T1 (de) 2011-07-15
DK1109831T3 (da) 2011-04-18
AU772176B2 (en) 2004-04-08
ATE495192T1 (de) 2011-01-15
WO2000012542A3 (en) 2000-06-29
WO2000012542A2 (en) 2000-03-09
WO2000012541A2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
ATE513847T1 (de) Bioaktive peptide
PT1086124E (pt) Ciclosporinas novas
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
ATE165100T1 (de) Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
ATE381578T1 (de) Peptide, basierend auf der sequenz des menschlichen lactoferrins und ihre anwendung
DE69900756D1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
DK1313440T3 (da) Dentalprodukter indeholdende knoglevækstforögende peptider
ATE317846T1 (de) Phosphoramidat-prodrugs
FR2741076B1 (fr) Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
HK1040237A1 (en) Fused polycyclic amino acids as pharmaceutical agents.
ATE371737T1 (de) Proteaseresistente flint-analoge
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
AR018328A1 (es) Forma cristalina de la 1s-[1 alfa(2s*,3r*), 9 alfa-]-6,10-dioxo-n-(2-etoxi-5-oxo-tetrahidro-3-furanil)-9-[[(1-isoquinolil)carbonil]amino]octahidro-6-h-piridazino[1,2-a][1,2] diazepina-1-carboxamida, su procedimiento de preparacion , su aplicacion en la preparacion de un medicamento, y las composicio
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees